New Hope in Fighting Breast Cancer: Understanding the Targeted Drug Verzenio (Abemaciclib)
Verzenio has opened a new window of hope for many patients with HR-positive, HER2-negative breast…
News
Is Melanoma Cancer Curable? 5 Powerful Facts for Hopeful Recovery
Melanoma cancer is a type of skin cancer that begins in the pigment-producing cells called…
Busting the “Lazy Cancer” Myth: China Launches Thyroid Cancer Awareness Day for Full-Cycle Care
Thyroid cancer is now the focus of a newly established national awareness day in China,…
How Bad Is Lymphoma Cancer? 5 Powerful Steps for Early Action
Lymphoma cancer is a type of cancer that begins in the lymphatic system, where abnormal…
Drug Update | Global New Drug Approvals (Sep 1–5, 2025)
DengYueMed reports the latest developments in global new drug approvals and submissions for early September…
Prostate Cancer Warning Signs: 5 Symptoms Every Man Should Know
Prostate cancer is the second most common cancer in men worldwide; it has become something…
Soaring 148%! China Medical Achieves Major Breakthrough with 39 Class-1 Innovative Drugs and 12 Poised for Approval
Source: Dengyuemed | September 27, 2025 | Category: Pharmaceuticals As a Hong Kong drug wholesale…
Latest FDA Decisions Expected in September 2025: Five Innovative Therapies Under Review
In 2024, the U.S. FDA approved more than 60 innovative therapies and vaccines, highlighting a…
5 Key Types of Lung Cancer Everyone Should Know for Early Action
Lung cancer is a disease where abnormal cells grow uncontrollably in the lungs, forming tumors…
Bristol-Myers Squibb’s Five-Year Immuno-Oncology Legacy in China: Delivering Long-Term Survival and Expanding Access
HKDengyuemed stated, “In cancer care, achieving five-year survival is a critical milestone, often synonymous with…
Copyright@ 2016-2024 Hong Kong Deng Yue Med Al Rights